Oncology Institute, Inc. has filed an 8-K report on March 13, 2026, which includes an investor presentation and financial statements as exhibits. The filing is part of the company's ongoing communication with investors and does not indicate any significant changes in governance or financial outlook. The investor presentation is available as Exhibit 99.1, providing insights into the company's current strategies and operational performance.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.